Suppr超能文献

间苯三酚联合缩宫素用于足月胎膜早破孕妇引产的疗效及安全性分析。

Efficacy and Safety Analysis of Phloroglucinol in Combination with Oxytocin for the Induction of Labor in Women with Term Premature Rupture of Membranes (PROM).

机构信息

Department of Obstetrics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, 317000 Zhejiang, China.

Department of Gynecology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, 317000 Zhejiang, China.

出版信息

Comput Math Methods Med. 2022 May 27;2022:2617075. doi: 10.1155/2022/2617075. eCollection 2022.

Abstract

OBJECTIVE

The purpose of this study was to investigate the efficacy and safety of phloroglucinol in combination with oxytocin in the induction of labor in women who had experienced term premature rupture of membranes (PROM).

METHODS

Data from 100 women who experienced PROM between December 2020 and December 2021 were retrospectively evaluated in this study. The puerperae were categorized into observation and control groups based on their uterine contraction regimens. The observation group consisted of 53 participants that had been treated with phloroglucinol in combination with oxytocin, and the control group consisted of 47 participants that had been treated with oxytocin alone. It was observed and compared in terms of the Bishop score before and after the administration of the puerpera to see which group had the best index. A study was performed after the drug was administered to examine its effects on the duration of labor (including the first, second, and third stages of labor), the mode of delivery (including natural vaginal delivery and cesarean section), the incidence of adverse pregnancy outcomes (fetal distress and neonatal asphyxia), successful labor induction, and complication rates.

RESULTS

Patients in the observation group had a significantly higher Bishop score after administration than those in the control group ( < 0.05), although there was no difference between the two groups before administration. In comparison to the control group, the observation group had a significantly higher efficacy rate for drug administration ( < 0.05), as well as a significantly lower occurrence of the first stage of labor ( < 0.05), a higher rate of vaginal natural delivery and successful induction of labor ( < 0.05), and a significantly lower incidence of adverse pregnancy outcomes and complications ( < 0.05).

CONCLUSION

In conclusion, the use of phloroglucinol in combination with intravenous oxytocin in the process of promoting cervical ripening and induction of labor for women with PROM who are at term was investigated. This study could help women speed up cervical dilation, improve the cervical Bishop scores, shorten the total labour process, improve the effective rate of vaginal delivery, and be very safe, making it a good candidate for clinical promotion and application.

摘要

目的

本研究旨在探讨间苯三酚联合缩宫素在足月胎膜早破(PROM)产妇引产中的疗效和安全性。

方法

本研究回顾性分析了 2020 年 12 月至 2021 年 12 月期间 100 例 PROM 产妇的数据。根据产妇子宫收缩方案将产妇分为观察组和对照组。观察组 53 例产妇采用间苯三酚联合缩宫素治疗,对照组 47 例产妇采用缩宫素单独治疗。观察并比较两组产妇用药前后的 Bishop 评分,以观察哪组指标最好。用药后进行研究,观察其对产程(包括第一、二、三产程)、分娩方式(包括自然阴道分娩和剖宫产)、不良妊娠结局(胎儿窘迫和新生儿窒息)、引产成功率和并发症发生率的影响。

结果

观察组产妇用药后 Bishop 评分明显高于对照组(<0.05),而用药前两组无差异。与对照组相比,观察组药物治疗有效率明显更高(<0.05),第一产程时间明显更短(<0.05),阴道自然分娩率和引产成功率明显更高(<0.05),不良妊娠结局和并发症发生率明显更低(<0.05)。

结论

综上所述,研究了间苯三酚联合静脉滴注缩宫素在足月 PROM 产妇促宫颈成熟和引产过程中的应用。这有助于加速宫颈扩张,提高宫颈 Bishop 评分,缩短总产程,提高阴道分娩率,且非常安全,是临床推广应用的良好选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验